Albendazole
(ABZ) is a poorly soluble anthelmintic drug that can
exist in amine and imine desmotropic forms. These facts can affect
the solubility and bioavailability of the drug product. Here, we investigate
the salt formation of ABZ with the acids HCl, HBr, and HNO3 associated with the tautomerism of the ABZ molecule. The reaction
of ABZ with an excess of the acids HCl, HBr, and HNO3 results
in the protonation of the imidazole ring, hiding the occurrence of
tautomeric states. Thus, the ABZ HCl, ABZ HBr, and ABZ HNO3 salts were obtained and characterized by single-crystal X-ray diffraction,
powder X-ray diffraction, FT-infrared spectroscopy (FTIR), differential
scanning calorimetry (DSC), thermal gravimetric analysis (TGA), and
aqueous solubility measurements. Furthermore, static and dynamic DFT
calculations were carried out to understand how the albendazolium
cation (ABZ-H+) is obtained from ABZ in amine and imine
forms. An analysis of crystal structures reveals that cations and
anions aggregate in 1D chains stabilized by NH···X
(X = Cl–, Br–, O–) interactions, generating layered structures. In solution, the intramolecular
amine ↔ imine conversion (ΔG
⧧ ≈ 50 kcal mol–1) and the solvent-mediated
deprotonation of the ABZ-H+ cation (ΔG
⧧ ≈ 20 kcal mol–1) requires
a higher energy barrier to occur, allowing the independence between
tautomers to propitiate the crystallization process. Consequently,
the process is dependent on the tautomer population in the starting
material. All salts were demonstrated to be more soluble than pure
ABZ. Given the good physical–chemical profile of these salts,
our results show a notable effect on the multicomponent crystal design,
manufacturability, and processing of the drug ABZ.